Crescent Biopharma Inc (Pre-Reincorporation)
NASDAQ:CBIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Crescent Biopharma Inc (Pre-Reincorporation)
NASDAQ:CBIO
|
US |
|
E
|
elf Beauty Inc
F:0EF
|
US |
|
B
|
BitNine Co Ltd
KOSDAQ:357880
|
KR |
|
I
|
IBI Investment House Ltd
TASE:IBI
|
IL |
|
S
|
Siam Wellness Group PCL
SET:SPA
|
TH |
|
V
|
Visa Inc
BMV:V
|
US |
|
R
|
Raspadskaya PAO
MOEX:RASP
|
RU |
|
Barry Callebaut AG
OTC:BRRLY
|
CH |
|
H
|
Heidelberger Beteiligungsholding AG
XETRA:IPOK
|
DE |
|
Consolidated Edison Inc
NYSE:ED
|
US |
|
Arko Corp.
NASDAQ:ARKO
|
US |
|
Laurentian Bank of Canada
TSX:LB
|
CA |
|
I
|
Industria de Diseno Textil SA
XMUN:IXD1
|
ES |
|
Entravision Communications Corp
NYSE:EVC
|
US |
Bankruptcy Probability
Crescent Biopharma Inc (Pre-Reincorporation)'s probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Crescent Biopharma Inc (Pre-Reincorporation) Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Crescent Biopharma Inc (Pre-Reincorporation)
NASDAQ:CBIO
|
694.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
450.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
206.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
179.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
54.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
46.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Crescent Biopharma Inc (Pre-Reincorporation)'s probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Crescent Biopharma Inc (Pre-Reincorporation) has no debt.
You can find a full breakdown on its Balance Sheet.
